KR970703784A - 브로멜라인의 의약적 용도 - Google Patents

브로멜라인의 의약적 용도

Info

Publication number
KR970703784A
KR970703784A KR1019960707424A KR19960707424A KR970703784A KR 970703784 A KR970703784 A KR 970703784A KR 1019960707424 A KR1019960707424 A KR 1019960707424A KR 19960707424 A KR19960707424 A KR 19960707424A KR 970703784 A KR970703784 A KR 970703784A
Authority
KR
South Korea
Prior art keywords
bromelain
medicament
preventing
manufacture
administering
Prior art date
Application number
KR1019960707424A
Other languages
English (en)
Korean (ko)
Inventor
트레시 리헤니 미노트
크리스천 인그워다
Original Assignee
크리스토퍼 로저스
코어텍스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크리스토퍼 로저스, 코어텍스 리미티드 filed Critical 크리스토퍼 로저스
Publication of KR970703784A publication Critical patent/KR970703784A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019960707424A 1994-06-24 1995-06-26 브로멜라인의 의약적 용도 KR970703784A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9412711.5 1994-06-24
GB9412711A GB9412711D0 (en) 1994-06-24 1994-06-24 Medical use of bromelain
PCT/GB1995/001501 WO1996000082A1 (en) 1994-06-24 1995-06-26 Medical use of bromelain

Publications (1)

Publication Number Publication Date
KR970703784A true KR970703784A (ko) 1997-08-09

Family

ID=10757263

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960707424A KR970703784A (ko) 1994-06-24 1995-06-26 브로멜라인의 의약적 용도

Country Status (13)

Country Link
EP (1) EP0766565A1 (xx)
JP (1) JPH10502073A (xx)
KR (1) KR970703784A (xx)
CN (1) CN1151119A (xx)
AU (1) AU2749395A (xx)
CA (1) CA2193654A1 (xx)
FI (1) FI965204A (xx)
GB (1) GB9412711D0 (xx)
IL (1) IL114331A0 (xx)
NO (1) NO965564L (xx)
TW (1) TW403654B (xx)
WO (1) WO1996000082A1 (xx)
ZA (1) ZA955292B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526691D0 (en) * 1995-12-29 1996-02-28 Cortecs Ltd Medical use of proteases
AU6303898A (en) * 1997-02-25 1998-09-18 Cortecs (Uk) Limited Component of bromelain
US20020102253A1 (en) * 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
ATE382084T1 (de) * 1997-02-25 2008-01-15 Sarantis Pty Ltd Bromelinbestandteil
NO304766B1 (no) 1997-06-16 1999-02-08 Sintef Fingeravtrykksensor
DE19726244C2 (de) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Verwendung proteolytischer Enzyme und Rutosid zur Vorbeugung bzw. Behandlung der Transplantatabstoßung
DE19726255C2 (de) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Beeinflussung von Cytokinen durch proteolytische Enzyme und Rutosid
DE19726254C2 (de) * 1997-06-20 1999-10-21 Mucos Pharma Gmbh & Co Toleranzinduktion durch Proteasen
GB9713667D0 (en) * 1997-06-27 1997-09-03 Cortecs Ltd Enhancement of intestinal permeability
GB9819138D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Nucleic acids and proteins from pineapple stem
GB9819137D0 (en) * 1998-09-02 1998-10-28 Cortecs Uk Ltd Component of bromelain
DE19847114A1 (de) * 1998-10-13 2000-04-20 Mucos Pharma Gmbh & Co Beeinflussung von hyperaktiven T-Zellen durch proteolytische Enzyme
WO2000035436A2 (en) * 1998-12-16 2000-06-22 Warner-Lambert Company Treatment of arthritis with mek inhibitors
DE19957318A1 (de) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Beeinflussung von TGF-Beta durch Proteolytische Enzyme
DE10018980A1 (de) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxe und Therapie von Diabetes mellitus I mit Hilfe proteolytischer Enzyme
EP1208849B1 (en) * 2000-11-28 2015-10-28 URSAPHARM Arzneimittel GmbH Use of bromelain for adjuvant therapy during wound healing process
TW201419131A (zh) 2012-11-09 2014-05-16 Health & Life Co Ltd 具語音輔助之生物感測裝置
US9526768B2 (en) * 2014-11-13 2016-12-27 Jennifer Mai Compositions for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225122A (ja) * 1983-05-23 1984-12-18 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
ES2072280T3 (es) * 1989-10-06 1995-07-16 Mucos Emulsions Gmbh Enzimas catabolicas para la induccion del factor de necrosis tumoral (tnf).
DE4302060A1 (de) * 1993-01-26 1994-07-28 Mucos Pharma Gmbh & Co Verwendung von Bromelain zur Krebstherapie und/oder Metastasen-Prophylaxe
GB9313188D0 (en) * 1993-06-25 1993-08-11 Cortecs Ltd Medical use of enzymes

Also Published As

Publication number Publication date
FI965204A0 (fi) 1996-12-23
EP0766565A1 (en) 1997-04-09
FI965204A (fi) 1997-02-21
CN1151119A (zh) 1997-06-04
NO965564L (no) 1997-02-24
ZA955292B (en) 1997-07-28
AU2749395A (en) 1996-01-19
WO1996000082A1 (en) 1996-01-04
NO965564D0 (no) 1996-12-23
TW403654B (en) 2000-09-01
IL114331A0 (en) 1995-10-31
CA2193654A1 (en) 1996-01-04
GB9412711D0 (en) 1994-08-17
JPH10502073A (ja) 1998-02-24

Similar Documents

Publication Publication Date Title
KR970703784A (ko) 브로멜라인의 의약적 용도
DE60113815D1 (de) Behandlung cytokin-vermittelter krankheiten mit tec familie protein tyrosin kinase inhibitoren
ATE164067T1 (de) Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen
GEP20032954B (en) Heterocyclic Inhibitors of P38
GEP20043363B (en) Indazole Compounds, Pharmaceutical Compositions, and Methods for Inhibiting Cell Proliferation
EP0765160A4 (xx)
ATE331503T1 (de) Tumornekrosefaktor alpha (tnf-alpha) hemmende arzneistoffe
DE60125541D1 (de) Neue nicht psychotropische cannabinoide
BR0212141A (pt) Inibidores de protease de cisteìna com estrutura 2-ciano-4-amino-pirimidina e atividade inibidora de catepsina k para o tratamento de inflamações e outras doenças
Xu et al. Osthole improves collagen-induced arthritis in a rat model through inhibiting inflammation and cellular stress
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
KR900702050A (ko) 축색성장 조절인자
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
BR9611897A (pt) Benzofurano carboxamidas e sulfonamidas
PT988043E (pt) Metodo e produto usando notocordio de esturjao para aliviar os sintomas de artrite
ATE259654T1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
BR0016415A (pt) Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico
ES2148268T3 (es) Composicion farmaceutica para prevenir o tratar fracturas de huesos.
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.
DE69932434D1 (de) Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten
ATE203671T1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid